Last reviewed · How we verify
NCT04575142
Comparison of Office-based KTP and CO2 Laser Outcomes in Patients With Vocal Cord Lesions.
NA trial testing CO2 laser in Laryngeal Diseases in 10 participants. Completed in 29 June 2021.
29 June 2021
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 26 January 2021 |
| Primary completion | 29 June 2021 |
| Estimated completion | 29 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CO2 laser
Conditions studied
- Laryngeal Diseases — all drugs for Laryngeal Diseases →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 88, any sex, with Laryngeal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test the outcomes of a CO2 laser device called AcuPulse Duo on vocal lesions and compare them to the most commonly used Aura KTP laser in order to determine which device has the best results. The CO2 laser device is an already FDA approved device. However, there have been no studies comparing the two devices for this use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04575142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CO2 laser
Trials testing the same drug.
- NCT06508788 — Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndro · recruiting
- NCT05995626 — Hyaluronidase Via LADD Scleroderma-induced Microstomia · EARLY_PHASE1 · completed
- NCT04111952 — The Effect of Additional Laser Treatments. · NA · unknown
- NCT05336825 — CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women · NA · completed
- NCT03433664 — Carbon Dioxide Laser Treatment in Burn-related Scarring · NA · completed
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04575142 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 24 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04575142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing